Overview

A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ustekinumab is effective in the treatment of moderate to severe hidradenitis suppurativa.
Phase:
Phase 2
Details
Lead Sponsor:
University Medical Center Groningen
Collaborator:
Janssen-Cilag B.V.
Treatments:
Ustekinumab